Inter-and intralaboratory reproducibility of susceptibility testing requires stable control strains. The Food and Drug Administration diffusion procedure recommends the Seattle strains of Staphylococcus aureus (ATCC 25923) and Escherichia coli (ATCC 25922) for this purpose. It was of interest to determine the present reproducibility of control cultures maintained in various laboratories over several years. Fifteen cultures each of S. aureus and E. coli were obtained from laboratories in different parts of the country. Their performance was compared with strains directly derived from ATCC. Diffusion susceptibility tests using a modified overlay technique were made with four replicates. Seven of the eight statistically significant differences in responses of the staphylococci were to penicillin, methicillin, or cephalothin. One culture was a penicillinase producer with a zone 15 mm less than the standard strain. Eleven of the 15 cultures showed no significant deviations or differences greater than 2 mm from the results with the strain derived directly from ATCC. All except the penicillinase producer were of identical phage type. Among 150 organism-antibiotic combinations tested with E. coli, all but one reading were within 2 mm of the standard. Four of the six statistically significant differences were in a culture from one laboratory. The stability of the cultures appears to have been influenced by the method of storage. Cultures that were kept frozen during extended storage were remarkably stable. Significant differences were found in cultures from four of five laboratories that maintained cultures in refrigerators or at ambient temperature.
Recommended quality control procedures for antimicrobial disk susceptibility tests require daily testing of Escherichia coli (ATCC 25922) and Staphylococcus aureus (ATCC 25923) (3, 4) . These strains, originally isolated and used for quality control purposes in the University of Washington Hospital Clinical Laboratories, have now been maintained in many different laboratories for up to 7 years. This has raised the possibility that contamination or genetic drift may have occurred in some clones similar to that which was shown with the Oxford Staphylococcus by Oeding and Ostervold (5) . A study was therefore designed to determine whether any differences could be detected in control strains used routinely in clinical laboratories.
Laboratories in different parts of the country were requested to send working cultures of their control strains with information on their original source, the date obtained, and maintenance procedures used. These cultures were then compared with strains derived directly from the American Type Culture Collection using a closely standardized agar overlay diffusion procedure.
MATERIALS AND METHODS Cultures. Cultures of E. coli and S. aureus submitted by 15 laboratories were tested. All were said to be derived from E. coli (ATCC 25922) and S. aureus (ATCC 25923) or from the "Seattle" control strains, which were the original source of the ATCC strains. The standard strains from the American Type Culture Collection with which all other cultures were compared had been subcultured only twice prior to the study.
Storage. The cultures from participating laboratories were streaked immediately upon receipt onto a blood agar plate and incubated overnight. One colony was inoculated into Biotyping of E. coli cultures. E. coli cultures were tested for the biochemical reactions listed in Table 31 of Edwards and Ewing (2) with the omission of KCN, gelatin, and cellobiose and the addition of nitrate, esculin, and trehalose. Reactions were read daily for 3 days.
Statistical analysis. An analysis of variance was performed on the S. aureus and E. coli data for each drug under study. The primary purpose was to estimate the variability associated with the mean response to each drug, where response was measured as the diameter of the zone of inhibition in millimeters. Components of variability associated with differences among laboratories, between readers, and between days were separated. Using the standard deviation estimated from the analysis of variance, Dunnett's t test for comparing multiple means to a control mean was performed to determine, separately for each drug, which laboratory means differed from the standard ATCC control strain (1 Table 1 , which lists all mean zone diameters that differed from the ATCC standard by more than 1 mm and identifies all statistically significant differences. The culture from laboratory 3 was not S. aureus ATCC 25923, as evidenced by its penicillin resistance and phage type. With the exception of one erythromycin zone, differences of >1 mm were only found with the penicillins and cephalothin. Cultures from laboratories 5, 9, and 20 showed zone sizes that were significantly different from the standard strain. Six of the 15 cultures did not differ from the standard strain by more than 1 mm with any antibiotic tested.
The mean zones of the standard strain and the ranges of the mean zone sizes for all 16 cultures of S. aureus, including the standard strain, are shown in Table 2 . The mean zone diameters are not comparable to control values recommended by FDA and NCCLS (3, 4) because a different technique was used which involved a heavier inoculum. Penicillin and cephalothin zones had the largest ranges. The right column lists the ranges for the 11 cultures that did not differ significantly (Table 1 ) from the standard. Reproducibility with these was excellent: only the mean penicillin zone sizes ranged more than 2 mm.
E. coli cultures. Twelve of the E. coli cultures showed identical reactions with the 30 biochemical tests. Three cultures (11, 20, and 22) differed in one reaction, and culture 5 differed in three reactions. The results of the susceptibility tests are summarized in Table 3 . Five cultures gave mean zone diameters differing from the standard strain by more than 1 tended storage with performance of the S. aureus cultures. None of the eight cultures that had been stored at -70°C showed any significant differences from the standard strain. One purporting to be of commercial origin was that which differed in phage type and penicillin susceptibility from the others. This was probably a case of contamination or error after receipt from the manufacturer, because FDA diffuson tests (3, 4) offour other S. aureus cultures from the same manufacturer indicated that they were satisfactory. Three of the five cultures stored in the refrigerator or at room temperature were found to show significant differences from the standard. Table 6 presents the correlation of methods and duration ofstorage with the performance of the E. coli cultures. Significant differences greater than 1.2 mm from the standard strains were found with two of the four cultures of E. coli that had been stored at room temperature.
There was no evidence of a relationship between duration of storage and stability of the cultures.
FDA diffusion tests. The 15 E. coli cultures and the standard were tested against the antibiotics listed above by the FDA diffusion test procedures (3, 4) . Four of 144 tests were outside FDA limits. On repeat tests all were within limits, except culture 5, which was again out of control with chloramphenicol. One result that was in control on the first test was 1 mm below the FDA limit for cephalothin on the repeat test. Results with carbenicillin, for which there are no FDA limits, were compared with the limits recommended by NCCLS. In the two series of tests, 9 of 32 carbenicillin zones were 1 to 2 mm below the recommended control values of 24 to 29 mm. The ATCC strain gave a mean value of 24.5 mm, and the overall mean of results from all strains was 24.2 mm. This suggests that the NCCLS limit may need revision.
The S. aureus cultures were also tested by the FDA diffusion test procedure. With the exception ofculture 3, which was the penicillinase producer, all cultures were within the FDA recommended control limits. Since no limits have been established for oxacillin, we calculated the limits to be 19 to 23 mm, based on over 200 measurements from the routine quality control procedures in our laboratory. Only culture 9 was out of control, having an oxacillin zone of 24 mm. On a repeat test, this culture was in control.
DISCUSSION
Quality control of antibiotic susceptibility testing presumes the stability of standard organisms. When inhibitory zone diameters are outside the limits of FDA or NCCLS recommendations, the sources of error will first be sought in media production or in technique. The results from this study, which used a highly reproducible diffusion procedure, indicate that there are detectable differences in the performance of standard E. coli and S. aureus cultures from different laboratories. With the exception of the penicillin-resistant culture, however, none of the S. aureus cultures was found to yield a zone diameter outside the FDA ranges when tested by the routine standardized diffusion test. Most of the significant changes in susceptibilities of the Staphylococcus were with the penicillins and cephalothin. This was especially evident when the data were expressed as ranges of mean zone diameters. However, cultures from 11 of the 15 laboratories showed no significant deviations from the results with the strain derived directly from ATCC.
In the case of E. coli cultures, four of the six significant differences were with a culture from one laboratory. When this culture and culture 5, which had a different biotype, are excluded, the ranges of the zone diameters did not exceed 1. 6 mm with any antibiotic tested. Only culture 5 was outside the FDA limits on both the initial and repeat tests using the standardized diffusion procedure. This culture had a light inner VOL. 10, 1976 on November 1, 2017 by guest http://aac.asm.org/ Downloaded from
